Official recommendations that discourage use of hotly debated screening test could be linked to increase, experts suggest ...

Prostate cancer often earns the label “silent killer” because it can develop and progress for years without producing noticeable symptoms. Understanding this timeline becomes crucial for men seeking ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...

A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer.

We are excited to bring the Alpha DaRT technology to prostate cancer patients in the U.S.,” said Dr. Robert B. Den, Alpha Tau ...

Archeus Technologies, a company developing multiple differentiated radiopharmaceutical therapies for the treatment of patients with cancer, today announced that it has dosed the first patient in its ...

PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...

As a physician, researcher, and biotech leader with personal experience of prostate cancer in my family, I’ve long advocated for putting patients first in our quest for medical innovation. Today, I ...

AdvanCell initiates Phase 2 expansion trial of ADVC001, a 212Pb-PSMA radioligand therapy, for metastatic prostate cancer.

Canadian research suggests recommendations against screening for prostate cancer has led to a rise in the rates of stage 4 ...

"You have cancer." It's a life-changing (and sometimes life-ending) development—a horrible piece of news no one is really ...

There is no single, diagnostic test. Doctors make a diagnosis based on various measures. This can include a prostate-specific ...